Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
Orthogon’s small molecule therapeutics redefine treatment possibilities for BK virus infections. December 10, 2024 07:57 AM Eastern Standard Time CANTON, Mass.–(BUSINESS WIRE)–Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an…